This is fabulous news!

Posted by: Staff

Thursday, October 25, 2012

Two advanced laboratory tests aimed at assessing breast cancer risks and guiding treatment options were recently approved for coverage for some TRICARE beneficiaries.


The tests –the BRACAnalysis BRCA1 and BRCA2 tests, and also, the Oncotype DX Breast Cancer Assay– assess breast cancer risks.  The BRACAnalysis tests a woman’s risk of developing hereditary breast or ovarian cancers based on mutations in their genes. The Oncotype DX breast cancer assay examines a breast cancer patient’s tumors at the molecular level which doctors say could help tailor the patient’s treatment.


Coverage for the tests is retroactive to May 2012, so TRICARE beneficiaries should contact their doctors to find out if they are eligible for having the tests performed as TRICARE benefit. To learn more, visit the TRICARE media site.


To read a detailed description of the tests, visit the Government Printing Office website.
To find regional TRICARE contractor contact information, visit the TRICARE “contact us” page.


Find more women’s health resources on